A tumor-derived mitochondrial tsRNA drives vascular invasion of lung adenocarcinoma by promoting ribosomal assembly in endothelial cells
Cancer Letters · 2026
DOI: 10.1016/j.canlet.2026.218324 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2026. Verfasst von Si Liang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital,…. Hauptthemen laut MEDLINE: Lung Neoplasms, Adenocarcinoma of Lung, Mitochondria, RNA, Mitochondrial. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jiangsu Provincial Medical Center, Jiangsu Cancer Hospital, National Natural Science Foundation of China.
Abstract (Originalsprache)
Vascular invasion is associated with metastasis and poor prognosis in patients with lung adenocarcinoma (LUAD). Recent studies have highlighted the role of intercellular mitochondrial transfer, mediated by both contact-dependent and contact-independent mechanisms, in tumor progression. Here, we reveal an abnormal accumulation of mitochondria in vascular endothelial cells invaded by tumor cells. Further in vivo and in vitro experiments demonstrated that tumor cells can transfer mitochondria with highly expressed mitochondrial tRNA-derived small RNAs (tsRNAs), mt-5'tiRNA-34-GlnTTG, to endothelial cells. Mechanistic investigations indicated that mt-5'tiRNA-34-GlnTTG binds to FUBP3 and facilitates its translocation, ultimately enhancing ribosomal assembly efficiency and translation rates in endothelial cells. This molecular cascade leads to increased endothelial cell proliferation and migration, thereby promoting LUAD metastasis. Moreover, we demonstrated the potential clinical translational value of lipid nanoparticles(LNPs) encapsulating mt-5'tiRNA-34-GlnTTG inhibitors in animal experiments. Utilizing LNPs encapsulating mt-5'tiRNA-34-GlnTTG inhibitors effectively suppressed lung cancer metastasis in in vivo models. These findings reveal a novel mechanism of LUAD progression mediated by mitochondrial tsRNA transfer and highlight a promising therapeutic strategy for limiting metastatic spread.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Thoracic Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, 210009, China; Jiangsu Key Laboratory of Molecular and Trans…
- Department of Anesthesiology, Jiangsu Cancer Hospital and Jiangsu Institute of Cancer Research and The Affiliated Cancer Hospital of Nanjing Medical University, No. 42, Baiziting, Nanjing, 210000, Jiangsu, China.
Förderung
- Jiangsu Provincial Medical Center
- Jiangsu Cancer Hospital
- National Natural Science Foundation of China
Zitieren
APA
Liang, S., Wang, Q., Zhang, M., Song, X., Zhang, Y., Wang, H., Feng, Y., Li, R., Xia, W., Xu, L., Dong, G., Mao, Q., & Jiang, F. (2026). A tumor-derived mitochondrial tsRNA drives vascular invasion of lung adenocarcinoma by promoting ribosomal assembly in endothelial cells. Cancer Letters. https://doi.org/10.1016/j.canlet.2026.218324
Vancouver
Liang S, Wang Q, Zhang M, Song X, Zhang Y, Wang H, et al. A tumor-derived mitochondrial tsRNA drives vascular invasion of lung adenocarcinoma by promoting ribosomal assembly in endothelial cells. Cancer Letters. 2026. doi:10.1016/j.canlet.2026.218324
BibTeX
@article{Liang2026,
author = {Liang, Si and Wang, Qinglin and Zhang, Minhao and Song, Xuming and Zhang, Yijian and Wang, Hui and Feng, Yipeng and Li, Rutao and Xia, Wenjie and Xu, Lin and Dong, Gaochao and Mao, Qixing and Jiang, Feng},
title = {A tumor-derived mitochondrial tsRNA drives vascular invasion of lung adenocarcinoma by promoting ribosomal assembly in endothelial cells},
journal = {Cancer Letters},
year = {2026},
doi = {10.1016/j.canlet.2026.218324}
}
EUVIMED